Anti-tumor effect of an anti-human Mullerian Inhibiting Substance type II receptor antibody in a nude mouse model for granulosa cell tumors: a new targeted therapy for ovarian cancer

被引：0
|
作者：
Kersual, N. [1 ]
Garambois, V. [1 ]
Salhi, I. [1 ]
Larbouret, C. [1 ]
Bibeau, F. [2 ]
Mollevi, C. [2 ]
Chardes, T. [1 ]
Pelegrin, A. [1 ]
Teulon, I. [1 ]
机构：
[1] Inst Rech Cancerol Montpellier, Montpellier, France
[2] Ctr Rech & Lutte Cancer, Montpellier, France
来源：
EJC SUPPLEMENTS | 2008年 / 6卷 / 12期
关键词：
D O I：
10.1016/S1359-6349(08)72447-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：163 / 163
页数：1
相关论文
共 16 条
  • [1] Antitumor effect of an anti-human mullerian inhibiting substance type II receptor antibody in a nude mouse model for granulosa cell tumors: a new targeted therapy for ovarian cancer
    Kersual, N.
    Garambois, V
    Salhi, I
    Larbouret, C.
    Bibeau, F.
    Cambon-Roques, S.
    Mollevi, C.
    Colombo, P. E.
    Theillet, C.
    Pelegrin, A.
    Teulon, I
    BULLETIN DU CANCER, 2008, 95 : S36 - S36
  • [2] Anti-tumor effect of an anti-human mullerian inhibiting substance type II receptor antibody in mouse models for ovarian cancer: towards a new targeted therapy
    Kersual, Nathalie A.
    Garambois, Veronique
    Salhi, Imed
    Chardes, Thierry
    Colombo, Pierre Emmanuel
    Bascoul-Mollevi, Caroline
    Cambon-Roques, Sylvie
    Bibeau, Frederic
    Pouget, Jean Pierre
    Behrens, Christian
    Gaucher, Christine
    Urbain, Remy
    Prose, Jean Frangois
    Pelegrin, Andre
    Navarro-Teulon, Isabelle
    CANCER RESEARCH, 2011, 71
  • [3] Towards a new targeted therapy for ovarian cancer : Development of an anti-human mullerian inhibiting substance type II receptor humanized antibody
    Jacquet, Alexandra
    Kersual, Nathalie
    Garambois, Veronique
    Colombo, Pierre-Emmanuel
    Goncalvez, Rui-Bras
    Theillet, Charles
    Gaucher, Christine
    Fournier, Nathalie
    De Romeuf, Christophe
    Prost, Jean-Francois
    Urbain, Remi
    Pelegrin, Andre
    Teulon-Navarro, Isabelle
    CANCER RESEARCH, 2011, 71
  • [4] 3C23K: an anti-human Mullerian inhibiting substance type II receptor humanized monoclonal antibody for ovarian cancer targeted therapy
    Jacquet, Alexandra
    Kersual, Nathalie
    Garambois, Veronique
    Fontayne, Alexandre
    Pujols, Fanny
    Fournier, Nathalie
    Pugniere, Martine
    Chavanieu, Alain
    de Romeuf, Christophe
    Prost, Jean-Francois
    Urbain, Remi
    Pelegrin, Andre
    Gaucher, Christine
    Teulon-Navarro, Isabelle
    CANCER RESEARCH, 2012, 72
  • [5] High level prokaryotic expression of anti-Mullerian inhibiting substance type II receptor diabody, a new recombinant antibody for in vivo ovarian cancer imaging
    Ortega, Celine
    Herbet, Amaury
    Richard, Sophie
    Kersual, Nathalie
    Costa, Narciso
    Pelegrin, Andre
    Ducancel, Frederic
    Couraud, Jean-Yves
    Navarro-Teulon, Isabelle
    Boquet, Didier
    JOURNAL OF IMMUNOLOGICAL METHODS, 2013, 387 (1-2) : 11 - 20
  • [6] Development of engineered antibodies specific for the Mullerian inhibiting substance type II receptor: a promising candidate for targeted therapy of ovarian cancer
    Yuan, Qing-an
    Simmons, Heidi H.
    Robinson, Matthew K.
    Russeva, Maria
    Marasco, Wayne A.
    Adams, Gregory P.
    MOLECULAR CANCER THERAPEUTICS, 2006, 5 (08) : 2096 - 2105
  • [7] Effect of an anti-human Co-029/tspan8 mouse monoclonal antibody on tumor growth in a nude mouse model
    Ailane, Naouel
    Greco, Celine
    Zhu, Yingying
    Sala-Valdes, Monica
    Billard, Martine
    Casal, Ibrahim
    Bawa, Olivia
    Opolon, Paule
    Rubinstein, Eric
    Boucheix, Claude
    FRONTIERS IN PHYSIOLOGY, 2014, 5
  • [8] Anti-Mullerian hormone inhibits growth of AMH type II receptor-positive human ovarian granulosa cell tumor cells by activating apoptosis
    Anttonen, Mikko
    Farkkila, Anniina
    Tauriala, Hanna
    Kauppinen, Marjut
    MacLaughlin, David T.
    Unkila-Kallio, Leila
    Butzow, Ralf
    Heikinheimo, Markku
    LABORATORY INVESTIGATION, 2011, 91 (11) : 1605 - 1614
  • [9] Anti-tumor effect of boron neutron capture therapy in pelvic human colorectal cancer in a mouse model
    Arima, Jun
    Taniguchi, Kohei
    Yamamoto, Masashi
    Watanabe, Tsubasa
    Suzuki, Yusuke
    Hamamoto, Hiroki
    Inomata, Yosuke
    Kashiwagi, Hideki
    Kawabata, Shinji
    Tanaka, Keitaro
    Uchiyama, Kazuhisa
    Suzuki, Minoru
    Lee, Sang-Woong
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 154
  • [10] Human ovarian cancer, cell lines, and primary ascites cells express the human mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS
    Masiakos, PT
    MacLaughlin, DT
    Maheswaran, S
    Teixeira, J
    Fuller, AF
    Shah, PC
    Kehas, DJ
    Kenneally, MK
    Dombkowski, DM
    Ha, TU
    Preffer, FI
    Donahoe, PK
    CLINICAL CANCER RESEARCH, 1999, 5 (11) : 3488 - 3499
12